Clinical Trial Update: Avastin for PDR (Proliferative Diabetic Retinopathy) [NA]

View source ↗

Summary

A completed clinical trial evaluated Avastin (bevacizumab) for proliferative diabetic retinopathy. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy
• Retinal Detachment

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Southern California | Conditions: Retinal Detachment, Diabetic Retinopathy | NA | Status: COMPLETED | Results posted: 2017-08-17